Skip to content
Disclosery

ORBIMED ADVISORS LLC: QURE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on QURE, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,807,486 QURE shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,807,486 shares
    Change vs previous 13F -328,663 shares

    1.58% of the 13F portfolio, value $83,252,805.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,136,149 shares
    Change vs previous 13F +1,398,749 shares

    0.76% of the 13F portfolio, value $34,926,036.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 737,400 shares
    Change vs previous 13F +278,900 shares

    0.36% of the 13F portfolio, value $17,645,982.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 458,500 shares
    Change vs previous 13F not available

    0.64% of the 13F portfolio, value $26,762,645.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).